A review of the effect of occlusive dressings on lamellar bodies in the stratum corneum and relevance to transdermal absorption

Dermatology Online Journal

Volumn 11, Issue 3, 2005, Pages

  Kennish, Lauren ^a   Reidenberg, Bruce ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b PURDUE PHARMA L P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLYCOSPHINGOLIPID; HYDROLASE; LANTHANUM; LIPID; PHOSPHOLIPID; STEROL DERIVATIVE;

DRUG DELIVERY SYSTEM; FLUID BALANCE; LAMELLAR BODY; MATHEMATICAL MODEL; PHYSIOLOGY; REVIEW; SKIN ABSORPTION; SKIN BLOOD FLOW; SKIN FUNCTION; SKIN PERMEABILITY; STRATUM CORNEUM; TISSUE REPAIR; WOUND DRESSING;

EID: 29844432699     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Reidenberg BE, El-Tahtawy A, Munera C, Cipriano A, Tonelli A, and Reder RF. Pharmacokinetics and Safety of Buprenorphine Transdermal System (BTDS) for 7 Day Application Comparing healthy Elderly and Young Adult Subjects. (Abstract 776, American Pain Society, November 2000)
2. Noveck R, Vargas R, McMahon GF, Breder CD, Spyker DA, Eltahtawy A, Munera C, Ganesan R, Wu D, and BE Reidenberg. PK of Buprenorphine Transdermal System (BTDS) Employing the LPS Pyrogen Model. (American Society for Clinical Pharmacology and Therapeutics, March 2001).
3. Lasseter KC, Venitz J, Eltahtawy A, Miotto J, Munera C, Reder R and BE Reidenberg. Systemic Pharmacokinetic (PK) Study of Buprenorphine (B) in Mild to Moderate Chronic Hepatic Impairment (CHI). (American Society for Clinical Pharmacology and Therapeutics, March 2001).
4. BE Reidenberg MD, CD Breder MD PhD, A Eltahtawy PhD, CL Creanga PhD, J. Miotto PhD and R Reder MD. Physiologic Effects of Buprenorphine Transdermal System (BTDS) Dose Escalation in the Young, Healthy Elderly and Elderly Hypertensive Subjects (Abstract 457.3, American Society for Pharmacology and Experimental Therapeutics, April 2001).
5. Reidenberg B, Eltahtawy A, Munera C, Cipriano A, Tonelli A, Reder R. Absolute bioavailability of a novel buprenorphine transdermal system (BTDS) applied for 7 days [abstract]. J Clin Pharmacol 2001;41:926.
6. Reidenberg B, Eltahtawy A, Munera C, Cipriano A, Tonelli A, Reder R. Daily pharmacokinetic performance of a buprenorphine transdermal system (BTDS) for up to 7 days [abstract]. J Clin Pharmacol 2001;41:1027.
7. Eltahtawy A, Cipriano A, McGoey D, Munera C, Reidenberg B. 7-Day bioavailability of buprenorphine from a novel transdermal system in demographic subgroups [abstract]. J Clin Pharmacol 2001;41:927.
8. Drug Reports for: fentanyl, buprenorphine (Transtec), selegiline, buspirone, estradiol, estradiol + progesterone, insulin (MicroPor system), and galanthamine. Retrieved August 28, 2001 from The Investigational and Drugs Database (IDdb3), Current Drugs Ltd., London, UK
9. Goldsmith LA, ed. Biochemistry and Physiology of the Skin. Oxford, New York, 1983: 1-63 and 1255-1295.
10. Moschella SL, Hurley HJ. Dermatology. W.B. Saunders Co., Philadelphia, 1992: pp. 1- 122.
11. Elias PM, Menon, GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Advances in Lipid Research. 24:1-26, 1991.
12. Loth H. Skin permeability. Methods & Findings in Exp & Clin Pharmacol. 11(3):155-64, 1989.
13. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol. 98(3):279-89, 1992.
14. Wertz PW, Downing DT. Stratum Corneum: Biological and Biochemical Considerations. In: Transdermal Drug Delivery. Hadgraft, J and Guy, RH (eds). Marcel Dekker, Inc, New York, 1989: pp. 1-22.
15. Elias PM, Feingold KR. Lipid-related barriers and gradients in the epidermis. Ann New York Acad Sci. 548:4-13, 1988.
16. Schaefer H, Zesch A, Stuttgen G. Skin Permeability. Springer-Verlag, Berlin, 1982
17. Elias PM, Cooper ER, Korc A, Brown BE. Percutaneous Transport in Relation to Stratum Corneum Structure and Lipid Composition. J Invest Dermatol. 76(4):297-301, 1981
18. Nemanic MK, Elias PM. In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J Histochem Cytochem. 28:573-578, 1980.
19. Bodde HE, Kruithoff MAM, Bursee J, Koerton,HK. Visualization of normal and enhanced HgCl2 transport through human skin in vitro. Int J Pharmacol. 53:13-24, 1989.
20. Menon GK, Elias PM. Morphologic Basis for a Pore-Pathway in Mammalian Stratum Corneum. Skin Pharmacol. 10:235-246, 1997.
21. Grubauer G, Elias PM, Feingold KR. 1989. Transepidermal water loss; the signal for recovery of barrier structure and function. J. Lipid Res. 30:323-333, 1989.
22. Jiang S, Koo S, Lee SH. The morphologic changes in lamellar bodies and intercorneocyte lipids after tape stripping and occlusion with a water vaporimpermeable membrane. Arch Dermatol Res. 290:145-151, 1998.
23. Taljebini M., Warren R, Mao-Oiang M, Lane E, Elias PM. Feingold KR. Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion. Skin Pharmacol. 9(2):111-9, 1996.
24. Aly R., Shirley C, Cunico B, Maibach HI> Efect of prolonged occlusion on the microbial flora, pH, carbon dioxide, and transepidermal water loss on human skin. J Invest Dermatol. 71:378-381, 1978.
25. Bucks, DAW, Maibach HI, Guy RH. Occlusion does not uniformly enhance penetration in vivo. In: Percutaneous Absorption: Mechanisms, Methodology, Drug Delivery, 2nd ed Bronaugh, RL, Maibach, HI (eds). Marcel Dekker Inc, NY, 1989: pp 77-93.
26. Zhai H, Maibach HI. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol. 14:1-10, 2001.
27. Sundberg S, Castrẑn M. Drug- and temperature-induced changes in peripheral circulation measured by laser-Doppler flowmetry and digital-pulse plethysmography. Scand J Clin Lab Invest. 46:359-365, 1986.
28. Ground S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet 38(1):59-89, 2000.
29. Benfeldt E. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects. Acta Dermato-Venereologica Supplementum. 206:1-59, 1999.
30. Rovee DT, Kurowsky RN, Labun J. Local wound environment and epidermal healing. Arch Dermatol. 106:330-334, 1972.